Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | TTRX Turn Therapeutics Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $13.04 -9.4% | $15.90 -2.5% |
| StockIQ Score | 52C- Moderate Risk: High | 41D Weak Risk: High |
| Technical | 62C+ | 36F |
| Fundamental | 37F | 35F |
| Growth | 38F | 50C- |
| Fair Value | 50C- | 38F |
| News | 86A | 50C- |
| Quality | — | 50C- |
| Risk | 34F | 40D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Turn Therapeutics (TTRX) outperforms Ascentage Pharma (AAPG) in most categories. Its technical score (62 vs. 36) and fundamental score (37 vs. 35) are notably stronger, while AAPG leads slightly in growth (50 vs. 38). Both have similar valuation scores (50 vs. 38), but TTRX’s overall investor score (52 vs. 41) and moderate rating suggest better investor confidence.
